Valuation: Baxter International Inc.

Market Cap 13.41B 11.58B 10.9B 9.9B 18.63B 1,285B 18.9B 128B 50.1B 643B 50.35B 49.26B 2,141B P/E 2026 *
33.3x
P/E 2027 * 21.7x
Enterprise Value 20.31B 17.54B 16.5B 15B 28.21B 1,946B 28.62B 194B 75.86B 973B 76.25B 74.59B 3,241B EV / Sales 2026 *
1.75x
EV / Sales 2027 * 1.66x
Free-Float
75.38%
Yield 2026 *
0.15%
Yield 2027 * 0.15%
1 day+0.12%
1 week-6.05%
Current month-0.84%
1 month+14.73%
3 months+45.81%
6 months+18.61%
Current year+35.74%
1 week 25.75
Extreme 25.75
27.45
1 month 21.4
Extreme 21.4
30
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Director of Finance/CFO 52 2026-03-15
Chief Tech/Sci/R&D Officer 57 2023-12-31
Director TitleAgeSince
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Director/Board Member 69 2021-02-14
Date Insider Type Main position Quantity % Market Cap.
5/5/26 Free

Director

12,836 0.0025%
2/27/26 Free

Chief Executive Officer

690,310 0.1343%
2/27/26 Free

General Counsel

92,700 0.0180%
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%-6.05%+9.87%-37.93% 13.41B
+2.09%+2.70%-13.50%+8.65% 195B
+1.64%+1.55%-0.78%+12.97% 118B
+1.16%-5.31%+8.88%+75.24% 60.33B
-3.33%-2.29%+28.78%+61.62% 55.1B
-0.72%-0.35%-7.30%-33.95% 49.24B
+0.95%+0.08%+10.86%-15.51% 33.81B
-2.18%-2.63% - - 29.94B
-0.01%-1.36%+42.58%-10.62% 24.39B
-4.11%-4.87%-11.27%+20.03% 23.82B
Average -0.44%-1.11%+7.57%+8.94% 60.29B
Weighted average by Cap. +0.53%+0.32%+0.54%+15.12%

Financials

2026 *2027 *
Net sales 11.62B 10.03B 9.44B 8.58B 16.14B 1,113B 16.37B 111B 43.4B 557B 43.62B 42.67B 1,854B 11.86B 10.25B 9.64B 8.76B 16.48B 1,137B 16.72B 113B 44.32B 568B 44.54B 43.57B 1,894B
Net income 372M 321M 302M 275M 517M 35.64B 524M 3.55B 1.39B 17.83B 1.4B 1.37B 59.38B 687M 594M 559M 508M 955M 65.87B 969M 6.55B 2.57B 32.94B 2.58B 2.53B 110B
Net Debt 6.9B 5.96B 5.6B 5.09B 9.58B 661B 9.72B 65.74B 25.77B 331B 25.89B 25.33B 1,101B 6.32B 5.46B 5.13B 4.67B 8.77B 605B 8.9B 60.21B 23.6B 303B 23.72B 23.2B 1,008B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
26-08-18 US$25.94 +0.12% 6,688,490
26-08-17 US$25.91 -3.07% 5,851,205
26-08-14 US$26.73 -1.18% 4,957,255
26-08-13 US$27.05 +0.37% 6,711,519
26-08-12 US$26.95 -2.39% 6,881,478
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
25.94USD
Average target price
28.73USD
Spread / Average Target
+10.75%

Quarterly revenue - Rate of surprise